| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030
Address all correspondence and requests for reprints to: John P. Lydon, Baylor College of Medicine, Department of Cell Biology, Room M523A, 1 Baylor Plaza, Houston, Texas 77030. E-mail: jlydon{at}bcm.tmc.edu
Previous investigations, in vitro, have demonstrated that progestins can induce the transcription of the cell cycle regulator, cyclin D1, thereby suggesting that cyclin D1 may mediate, at the molecular level, the proposed mitogenic effects of progesterone during mammary epithelial cell proliferation. To extend these initial studies into an in vivo context, comparative cyclin D1 Northern and immunohistochemical analyses were performed on mammary gland tissue isolated from wild type (WT) females as well as from the recently reported progesterone receptor knockout (PRKO) mouse model. Northern analysis revealed that estrogen induced cyclin D1 expression, 5- to 7-fold over control levels, both in the WT and PRKO female. Immunohistochemistry demonstrated that, for both test groups, the number of mammary epithelial cells expressing cyclin D1 increased significantly as compared with control values, in response to estrogen. In the case of estrogen plus progesterone treatment, Northern analysis revealed that, in the WT gland, cyclin D1 transcription increased approximately 3-fold over estrogen induced levels, an increase that was paralleled by an equivalent increase in the number of mammary epithelial cells expressing cyclin D1. Conversely, under the same hormone regimen, the PRKO mammary gland did not exhibit a further increase in cyclin D1 induction over estrogen only levels. Finally, these studies not only demonstrate that in the mammary epithelial cell, both estrogen and progesterone can induce the expression of cyclin D1 but also show that this induction correlates with mammary gland proliferation in the mouse.
This article has been cited by other articles:
![]() |
C. Otto, I. Fuchs, H. Altmann, M. Klewer, A. Walter, K. Prelle, R. Vonk, and K.-H. Fritzemeier Comparative Analysis of the Uterine and Mammary Gland Effects of Drospirenone and Medroxyprogesterone Acetate Endocrinology, August 1, 2008; 149(8): 3952 - 3959. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Aupperlee and S. Z. Haslam Differential Hormonal Regulation and Function of Progesterone Receptor Isoforms in Normal Adult Mouse Mammary Gland Endocrinology, May 1, 2007; 148(5): 2290 - 2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Boonyaratanakornkit, E. McGowan, L. Sherman, M. A. Mancini, B. J. Cheskis, and D. P. Edwards The Role of Extranuclear Signaling Actions of Progesterone Receptor in Mediating Progesterone Regulation of Gene Expression and the Cell Cycle Mol. Endocrinol., February 1, 2007; 21(2): 359 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mussi, L. Liao, S.-E. Park, P. Ciana, A. Maggi, B. S. Katzenellenbogen, J. Xu, and B. W. O'Malley Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland PNAS, November 7, 2006; 103(45): 16716 - 16721. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Shi, J. P. Lydon, and M. Zhang Hormonal Defect in Maspin Heterozygous Mice Reveals a Role of Progesterone in Pubertal Ductal Development Mol. Endocrinol., September 1, 2004; 18(9): 2196 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cicatiello, R. Addeo, A. Sasso, L. Altucci, V. B. Petrizzi, R. Borgo, M. Cancemi, S. Caporali, S. Caristi, C. Scafoglio, et al. Estrogens and Progesterone Promote Persistent CCND1 Gene Activation during G1 by Inducing Transcriptional Derepression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) Complex Assembly to a Distal Regulatory Element and Recruitment of Cyclin D1 to Its Own Gene Promoter Mol. Cell. Biol., August 15, 2004; 24(16): 7260 - 7274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yeh, Y.-C. Hu, P.-H. Wang, C. Xie, Q. Xu, M.-Y. Tsai, Z. Dong, R.-S. Wang, T.-H. Lee, and C. Chang Abnormal Mammary Gland Development and Growth Retardation in Female Mice and MCF7 Breast Cancer Cells Lacking Androgen Receptor J. Exp. Med., December 15, 2003; 198(12): 1899 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Lanz, S. S. Chua, N. Barron, B. M. Soder, F. DeMayo, and B. W. O'Malley Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo Mol. Cell. Biol., October 15, 2003; 23(20): 7163 - 7176. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chou, N. Uehara, J. R. Lowry, and G. Shyamala Mammary epithelial cells of PR-A transgenic mice exhibit distinct alterations in gene expression and growth potential associated with transformation Carcinogenesis, March 1, 2003; 24(3): 403 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Ismail, J. Li, F. J. DeMayo, B. W. O'Malley, and J. P. Lydon A Novel LacZ Reporter Mouse Reveals Complex Regulation of the Progesterone Receptor Promoter During Mammary Gland Development Mol. Endocrinol., November 1, 2002; 16(11): 2475 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Smith, D. G. DeVera, D. J. Lamb, Z. Nawaz, Y.-H. Jiang, A. L. Beaudet, and B. W. O'Malley Genetic Ablation of the Steroid Receptor Coactivator-Ubiquitin Ligase, E6-AP, Results in Tissue-Selective Steroid Hormone Resistance and Defects in Reproduction Mol. Cell. Biol., January 15, 2002; 22(2): 525 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Ma, Z. Liu, E. S. W. Ngan, and S. Y. Tsai Cdc25B Functions as a Novel Coactivator for the Steroid Receptors Mol. Cell. Biol., December 1, 2001; 21(23): 8056 - 8067. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Thordarson, K. Van Horn, R. C. Guzman, S. Nandi, and F. Talamantes Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones Carcinogenesis, July 1, 2001; 22(7): 1027 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Said, R. C. B. Moraes, U. Singh, F. S. Kittrell, and D. Medina Cyclin-dependent Kinase (cdk) Inhibitors/cdk4/cdk2 Complexes in Early Stages of Mouse Mammary Preneoplasia Cell Growth Differ., June 1, 2001; 12(6): 285 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Foster, D. C. Henley, A. Bukovsky, P. Seth, and J. Wimalasena Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 Function Mol. Cell. Biol., February 1, 2001; 21(3): 794 - 810. [Abstract] [Full Text] |
||||
![]() |
C. Brisken, A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S. K. Dey, J. A. McMahon, A. P. McMahon, and R. A. Weinberg Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling Genes & Dev., March 15, 2000; 14(6): 650 - 654. [Abstract] [Full Text] |
||||
![]() |
O. M. Conneely, J. P. Lydon, F. De Mayo, and B. W. O'Malley Reproductive Functions of the Progesterone Receptor Reproductive Sciences, January 1, 2000; 7(1_suppl): S25 - S32. [Abstract] [PDF] |
||||
![]() |
J. P. Lydon, G. Ge, F. S. Kittrell, D. Medina, and B. W. O'Malley Murine Mammary Gland Carcinogenesis Is Critically Dependent on Progesterone Receptor Function Cancer Res., September 1, 1999; 59(17): 4276 - 4284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. VEGETO, G. POLLIO, C. PELLICCIARI, and A. MAGGI Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-{alpha}-induced apoptosis FASEB J, May 1, 1999; 13(8): 793 - 803. [Abstract] [Full Text] |
||||
![]() |
F. Vazquez, J. C. Rodriguez-Manzaneque, J. P. Lydon, D. P. Edwards, B. W. O'Malley, and M. L. Iruela-Arispe Progesterone Regulates Proliferation of Endothelial Cells J. Biol. Chem., January 22, 1999; 274(4): 2185 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Le Bihan, V. Marsaud, C. Mercier-Bodard, E.-E. Baulieu, S. Mader, J. H. White, and J.-M. Renoir Calcium/Calmodulin Kinase Inhibitors and Immunosuppressant Macrolides Rapamycin and FK506 Inhibit Progestin- and Glucocorticosteroid Receptor-Mediated Transcription in Human Breast Cancer T47D Cells Mol. Endocrinol., July 1, 1998; 12(7): 986 - 1001. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |